We Dabble in a Little Bit of This and a Lot of That
CLS Holdings, better known as Cannabis Life Sciences, is an integrated cannabis producer and retailer serving the discerning consumer through our brands, City Trees and Oasis Cannabis. Our patented proprietary method of extracting cannabinoids from the marijuana plant includes converting them into products with a higher level of quality and consistency.
We are a true seed to sale, vertically integrated company leading the cannabis industry. City Trees is where it all begins. Our warehouse includes 10,000 square feet of dedicated space for cultivation, allowing us to grow and preserve high-quality stock with valuable genetics that yields consistent results. Oasis Cannabis is where we share our love of cannabis with the public. Located in Downtown Las Vegas, Oasis is our 5,000 square foot retail location offering personalized delivery, pick-up, and in-store experiences.
Company Milestones – A Developing Legacy in the Cannabis Market
Completed the Purchase of Oasis Cannabis Dispensary in Las Vegas
Completed the Purchase of City Trees Production and Innovation Facility in North Las Vegas
Successfully Completed Multiple Capital Infusions
Rapid Growth of Oasis Brand
Completed the Build-out of $4M State of the Art Conversion and Extraction Facility Capable of Producing $20M in Revenue
Obtained Patents for Extraction IP in the US, EU, and Canada
USD $7.5M in Cash and Current Assets
Expansive Growth for the Future
We are poised to expand our business significantly as the need and desire for cannabis expand in the Nevada market and its large tourist base.
Harvesting the Best Marijuana Has to Offer
Our proprietary method of extracting cannabinoids generates a higher level of effect-based or strain-specific extracts that can be concentrated into oils, waxes, edibles, and shatter. We believe this proprietary process and the ability to manufacture these refined cannabinoids provide us with a strategic advantage in the cannabis industry.
Proprietary Methods of Extraction and Conversion
Ray Keller, a shareholder of CLS, and a founder of CLS Labs, developed our US patented proprietary process for extracting, cleaning, and converting cannabinoids from cannabis plants. This proprietary extraction and conversion methodology allows for cannabinoid concentrates to be ingested in several ways, including through vaporization and used for a variety of pharmaceutical and other purposes.
Our proprietary process produces a cleaner, higher quality product, and a significantly higher yield than most cannabinoid extraction processes currently existing in the marketplace.
Partner with an Innovator in the Cannabis Market
Grow with Us and Plant Roots in Nevada and Beyond
Partnerships are vital for the awareness, growth, and sustainability of the cannabis market. Partnering with CLS supports our ongoing science-based focus to create a thriving business model supporting our stakeholders, employees, and customers.
Taking CLS to the Next Level
Leadership that Brings a Full Spectrum of Experience to the Future
Our leadership team stems from innovators who focus on science, business, and community involvement to strengthen our company and our 75 plus employees. Together, we see the future of cannabis and believe we are at the forefront of this emerging market.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty six hundred dollars for CLS Holdings USA, Inc. current news coverage by the company. FNMG HOLDS NO SHARES OF CLS Holdings USA, Inc.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.